Table 2. Prevalence and standardised prevalence ratio of monkeypox vaccination and self-isolation intention, the Netherlands, July 2022 (n=394).

Sub-population	Vaccination intention (Extremely likely vs rest of scale)a					Monkeypox self-isolation intention (Extremely likely vs rest of scale)a
	Prevalence		95%CI	SPRb	95%CI	Prevalence		95%CI	SPRb	95%CI
	n	%				n	%
PrEP users	178	73.86	67.97–79.00	1.01	0.87–1.17	105	43.57	37.45–49.81	1.06	0.87–1.28
Non-PrEP users	87	71.31	62.73–78.59	0.97	0.78–1.19	43	35.25	27.34–33.06	0.86	0.63–1.14
Total sample	276	70.01	65.35–74.36	NA	NA	173	43.91	39.09–48.84	NA	NA

CI: confidence interval; NA: not applicable; PrEP: pre-exposure prophylaxis; SPR: standardised prevalence ratio.

^a 1−5 Likert scale, with 1 = extremely unlikely and 5 = extremely likely)

^b Adjusted for PrEP use status.